Human immune globulin treatment controls Zika viremia in pregnant rhesus macaques
Fig 4
Plaque reduction neutralizing antibody titers (90%) of ZIKV-IG and placebo-IG-treated animals.
Longitudinal neutralizing antibody titers of ZIKV-IG-treated animals (red). Placebo-IG PRNT90 titers were measured at 0 and 27 dpi only (blue). Dotted vertical lines represent the time point 1 hour post-ZIKV-IG infusion for reference. Mean titers with 95% CI are plotted.